207940.KS
Samsung Biologics Co.,Ltd.
KSC · Healthcare · Biotechnology · KR
KRW 1,477,000.00
−1.60%Forward multiples
Based on analyst estimates
- P/E forward
- 32.44x
- P/E 2026E
- 35.03x
- P/E 2027E
- 29.53x
- P/E 2028E
- 26.33x
- P/S forward
- 11.43x
Trailing multiples
Trailing twelve months
- P/E TTM
- 34.44x
- PEG TTM
- 5.48x
- Price / book
- 8.17x
- Price / sales
- 15.02x
- Price / cash flow
- 28.06x
Enterprise value
- Enterprise value
- KRW 67.35T
- EV / sales
- 14.81x
- EV / EBITDA
- 22.80x
- EV / EBIT
- 33.89x
- Market cap
- KRW 68.30T
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026